In view of our recent findings implicating the DAMP-TLR4 axis in driving sustained fibroblasts activation underlying fibrosis progression in SSc, we sought to investigate the effect of TAK242 in preclinical models of organ fibrosis, and in SSc fibroblasts. The gene discussed is TLR4; the disease is systemic sclerosis.